Insurance Coverage for Erectile Dysfunction Drugs
Hornbrook, M C
Clinical pharmacology and therapeutics 2011 Jan; 89(1): 19-21
Showing items related by title, author, creator and subject.
Where Cost, Medical Necessity, and Morality Meet: Should US Government Insurance Programs Pay for Erectile Dysfunction Drugs? Polinski, J M; Kesselheim, A S (2011-01)Spending for the three most popular phosphodiesterase (PDE) inhibitor drugs to treat erectile dysfunction (ED) tops $1 billion worldwide annually. Using Medicaid and Medicare Part D as examples, we explore here whether US ...